Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy

New York University Medical Center, New York

Mt. Sinai School of Medicine, New York

Columbia University Medical Center, New York

Moffitt Heart & Vascular, Wormleysburg

Hospital of the University of Pennsylvania, Philadelphia

Carolinas Medical Center, Charlotte

Emory University, Atlanta

Florida Hospital, Orlando

Baptist Hospital of Miami, Miami

Zasa Clinical Research, Atlantis

St. Thomas Research Institute, Nashville

Cardiology Associates of N. Mississippi, Tupelo

Central Baptist Hospital, Lexington

Cleveland Clinic, Cleveland

Lindner Clinical Trial Center, Cincinnati

William Beaumont, Royal Oak

University of Michigan Medical Center, Ann Arbor

Iowa Heart Center, Des Moines

St. Luke's Hospital, Milwaukee

Abbott Northwestern Hospital, Minneapolis

Mayo Clinic, Rochester

North Shore University, Evanston

St. John's Mercy, St Louis

St. Luke's Hospital, Kansas City

Bryan LGH, Lincoln

Baylor Research Institute, Dallas

Methodist Hospital, Houston

Texas Cardiac Arrhythmia, Austin

Intermountain Medical Center, Salt Lake City

Arizona Heart Rhythm Research Center, Scottsdale

Mercy Gilbert Medical Center, Gilbert

Cedars-Sinai Medical Center, Los Angeles

St. John's Hospital / Pacific Heart, Santa Monica

Foundation for Cardiovascular Medicine, La Jolla

Scripps Green, La Jolla

Orange County Heart, Orange

Swedish Medical Center, Seattle

Massachusetts General Hospital, Boston

Lahey Clinic, Burlington

Englewood Hospital and Medical Center, Englewood

Fletcher Allen, Burlington